Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy

NCT02377648 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Allograft Vasculopathy

Interventions

DEVICE: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)

Sponsor

Universita di Verona